Bovine Colostrum for Gluten Intolerance
Trial Summary
Do I need to stop taking my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are using an oral digestive enzyme supplement, you must stop it 72 hours before each study visit.
What data supports the effectiveness of the treatment Bovine Colostrum for Gluten Intolerance?
Bovine colostrum has been shown to have antibacterial effects and can help modulate the immune system, which may provide gastrointestinal benefits. It has been used to treat diarrhea in people with immune deficiencies and may help with gut health, suggesting potential benefits for gluten intolerance.12345
Is bovine colostrum safe for human consumption?
How does the treatment bovine colostrum differ from other treatments for gluten intolerance?
Bovine colostrum is unique because it contains high levels of immunoglobulins (proteins that help fight infections), growth factors, and antimicrobial peptides, which may help improve gut health and reduce symptoms of gluten intolerance. Unlike standard treatments, it is a natural product that supports the immune system and gut lining, potentially offering a holistic approach to managing gluten intolerance.56101112
What is the purpose of this trial?
This trial investigates whether hyperimmune bovine colostrum can help people on a strict gluten-free diet by reducing the amount of gluten their bodies absorb. The colostrum works like a sponge, soaking up gluten to prevent it from causing problems.
Research Team
Jocelyn Silvester, MD PhD
Principal Investigator
Beth Israel Deaconess Medical Center
Eligibility Criteria
This trial is for healthy volunteers who have been strictly gluten-free for at least 3 months, whether due to celiac disease, non-celiac gluten sensitivity, or personal choice. Participants must not have active gastrointestinal diseases, severe reactions to gluten or milk proteins, recent use of digestive enzymes, certain medical conditions or medications as judged by the investigators, and cannot be pregnant.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-treatment
Participants receive daily proton pump inhibitor (PPI) therapy (omeprazole 20 mg) at least one week before the first intervention
Treatment
Participants undergo a double-blind, cross-over study with gluten challenges with either bovine colostrum or placebo
Follow-up
Participants are monitored for safety and effectiveness after treatment, including adverse event recording and patient-reported outcomes
Treatment Details
Interventions
- Bovine colostrum
- Placebo
Find a Clinic Near You
Who Is Running the Clinical Trial?
Milky Way Life Sciences LLC
Lead Sponsor
Beth Israel Deaconess Medical Center
Collaborator